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Abstract 20 
The palatability of medicines is likely to have a significant impact on patient adherence and 21 
consequently, on the safety and efficacy of a medicinal product. Palatability encompasses 22 
properties of medicines not limited to taste including swallowability (e.g. size, shape, 23 
texture). However, there has been limited work undertaken to measure the texture of 24 
medicines and how this may affect palatability and subsequent adherence. 25 
Tribology offers an understanding of oral processes and can allow physical properties of 26 
materials to be linked to “mouthfeel”. This paper describes a preliminary application of 27 
tribology to oral liquid medicines and demonstrates that this technique is useful in the 28 
development of future oral liquid medicines.  29 
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Medicine  Tribology  acceptability  35 
1 Introduction 36 
Patient acceptability is likely to have a significant effect on medicines adherence and 37 
consequently on the safety and efficacy of the medicinal product. Recent EMA guidelines 38 
have highlighted that the palatability of a medicine is one of the main elements of patient 39 
acceptability of an oral paediatric medicinal product (EMA, 2013). Palatability is defined as 40 
the overall appreciation of a medicinal product in relation to its smell, taste, aftertaste and 41 
texture (i.e. feeling in the mouth). It is determined by the characteristics of the active 42 
substance, the way the active substance is formulated into a finished medicinal product and 43 
by the characteristics of the excipients.  44 
Much work has been done on the assessment of taste of medicines (e.g. (Baguley et al., 45 
2012; Rieder, 2012; Smith et al., 2013; Somasiri et al., 2013)) but there are very limited 46 
reports on the influence of texture of medicines. Allué et al (2012) evaluated the organoleptic 47 
properties of oral rehydration solutions in children, including the influence of texture by 48 
comparing a “gelatine” and “gel” texture; their results showed that the “gel” texture was 49 
preferred however, no further details on this finding were provided  (Polanco Allué et al., 50 
2012). The need to improve the texture of medicines was also highlighted for antiretroviral 51 
therapies (2004; Gibb et al., 2003), although details on textural issues were not explicitly 52 
reported. The texture of nelfinavir powder has been reported to be an issue in terms of 53 
palatability of medicines (Reddington et al., 2000; Van Dyke et al., 2002). Nelfinavir is 54 
administered in large volumes, for instance, at the dose of 55 mg/kg BID, an average 6-year-55 
old is required to take 25 scoops (6.25 teaspoons) of nelfinavir powder, with food, twice a 56 
day. 57 
A recent study investigated barriers to medicines administration in children and although 58 
taste was the most reported issue in medicines refusal texture was the next most frequent 59 
reason for refusal (Venables et al., 2014). Specific medicines identified with textural issues 60 
included: lactulose which was described as “oily” and co-trimoxazole liquid described as 61 
“thick and gelatinous” (Venables, 2014).  62 
There are no reports on the ideal mouthfeel of a liquid medicine; however it is intuitive to 63 
suggest that this needs to be smooth and in the case of a bad tasting medicine a product 64 
that is swallowed rapidly and leaves minimal residue on the oral cavity surfaces. Positive 65 
attributes of oral formulations reported in a recent study described good textures as being 66 
“sherbet” and “fizzy” (Venables, 2014).  67 
The mouthfeel of a medicine can be defined as the sensation from the ingestion, mastication 68 
and swallowing of the medicine, all of which are influenced by the physical and chemical 69 
properties of the medicine being administered. The majority of mouthfeel research has been 70 
conducted on foods where there is a tendency to want to maximise sensory pleasure in food 71 
consumption to drive preferences in food choices, however, there are key differences 72 
required in assessing the mouthfeel of medicines. Medicines are designed to be acceptable 73 
rather than preferred choices and there is no requirement to maximise sensory pleasure. 74 
Nevertheless, it is critical that the mouthfeel of a medicine is not a barrier to administration. 75 
Orally administered medicines are manipulated by the tongue, teeth, inside of the cheeks 76 
and lips whilst in the oral cavity; this subjects the medicine to forces at a range of speeds 77 
and pressures (Prinz et al., 2007). There are various sensory textural attributes that patients 78 
perceive whilst taking oral medicines (as with foods) including hardness, softness, grittiness, 79 
creaminess, adhesiveness, slipperiness and many others (De Wijk and Prinz, 2006). 80 
Research in food science has attempted to qualify and quantify physical properties of foods 81 
and link in vitro measurements to sensory attributes. For example, rheological properties 82 
have been linked to thickness and breaking forces linked to crispiness (Koliandris et al., 83 
2010; van Vliet et al., 2009). Tribology is considered the most appropriate method to 84 
measure phenomena related to attributes such as creaminess, slipperiness and coating of a 85 
liquid on oral surfaces as these are sensations associated with rubbing and squeezing 86 
actions within the mouth. Tribology is the study of thin film lubrication (Prakash et al., 2013). 87 
The use of tribology for the study of friction and the behaviour of foods is a relatively new 88 
application of this measurement system which has been shown to differentiate foods on the 89 
basis of their creaminess (Chojnicka-Paszun et al., 2012; Dresselhuis et al., 2008; Sonne et 90 
al., 2014) and other textural parameters (Mills and Norton, 2013).  In general, it is accepted 91 
that while tribology does not provide a one-to-one relation to processing in the mouth, when 92 
combined with a number of other characterisation techniques such as rheology, it can offer 93 
valuable information on material behaviour.  This knowledge can then be used to help guide 94 
the design of new products.  This paper describes the first use of tribology to assess the 95 
lubricating properties of oral liquids. 96 
In brief, tribology measures the friction between two interacting surfaces, in this case a steel 97 
ball on a silicone elastomer disk. Lubrication is often categorised by measuring the friction 98 
coefficient across a range of speeds as the extent of lubrication will vary. Often this data is 99 
presented as a Stribeck curve, which shows the traction coefficient as a function of speed of 100 
motion between surfaces. The Stribeck curve usually has three phases: 101 
1. Boundary regime: where the speed is low, this measures the ability of the fluid to wet 102 
or adsorb to the surface and has in some cases been linked to astringency/grittiness 103 
(Rossetti et al., 2009)(high value of friction) and slipperiness/oiliness (low value of 104 
friction)(Malone et al., 2003; Prakash et al., 2013). 105 
2. Mixed regime: where the speed is intermediate and the fluid present can partly 106 
separate the two rubbing surfaces. The friction coefficient reaches a minimum in this 107 
regime and typically lower values have been associated with creamy textures 108 
(Chojnicka-Paszun et al., 2012). 109 
3. Hydrodynamic regime: where the speed is high and the fluid separates the surfaces; 110 
the film thickness and friction generated are dependent upon the viscosity of the 111 
food. Often rheology provides greater insights at these speeds to characterise the 112 
fluid present. 113 
In terms of application of tribology to liquid medicines in the mouth we are mostly interested 114 
in low to intermediate speed movement (boundary/mixed regime as described above) to 115 
assess the ability of a medicine to coat the oral cavity as we hypothesise that a low-residue 116 
(non-coating) product is likely to be preferred and it is these regions that have previously 117 
been identified to be most relevant when considering oral processing (Malone et al., 2003). 118 
Many oral liquid medicines are formulated as suspensions where drug particles are 119 
undissolved within the bulk liquid. The size of the drug particles will influence their mouthfeel 120 
as they may result in a gritty texture. Previous work conducted reported that particles as 121 
small as 2 µm could be detected in food by trained adult panels (Engelen et al., 2005a). 122 
However, the perception of size of particles was influenced by their characteristics where 123 
hard and irregular particles are perceived as larger than soft and round particles of similar 124 
size (Engelen et al., 2005b). 125 
The objective of the present study is to evaluate the effectiveness of tribology as a tool to 126 
differentiate between oral liquid medicines based on qualitative feedback regarding their 127 
texture. The frictional response of each liquid is measured over a range of speeds to map 128 
the Stribeck response for each product and compared with viscosity to emphasise the 129 
different information that can be gained from this method. We highlight the potential of 130 
tribological measurement to provide insights into texture and mouthfeel perception of 131 
medicines. 132 
2 Materials and methods 133 
2.1 Medicinal products  134 
Oral liquid medicines were selected based on qualitative data from previous work where co-135 
trimoxazole (Septrin®) and Lactulose were reported as having thick and oily textures 136 
respectively (Venables, 2014). Calpol® infant sugar free 120mg/5mL suspension is typically 137 
reported to be an ideal medicine in terms of palatability and therefore this was used as a 138 
control. Other generic paracetamol suspensions were investigated to observe whether 139 
tribology could differentiate between brands.  140 
Septrin® Paediatric suspension 40mg/200mg per 5mL (Aspen); Septrin® adult suspension 141 
80mg/400mg per 5mL (Aspen); generic paracetamol sugar free oral suspension 120mg per 142 
5mL (Edict); Calpol® paracetamol sugar free oral suspension 120mg per 5mL (McNeil); 143 
generic paracetamol sugar free oral suspension 250mg per 5mL (Pinewood laboratories); 144 
lactulose (TEVA UK) were sourced from a local pharmacy (Queen Elizabeth Hospital 145 
Pharmacy) and used as received.  146 
2.2 Tribology apparatus and measurement 147 
The friction properties were measured using a mini traction machine (MTM2 PCS 148 
Instruments, London).  The machine consists of a 19.05 mm steel ball loaded onto a 46mm 149 
diameter silicone elastomer disc, which are independently driven to allow different relative 150 
motion.  Temperature was controlled at 20 °C. Typically medicines are retained in the mouth 151 
for <20 seconds therefore 20 °C is more representative of the temperature of the product 152 
compared to body temperature (37 °C).  Stribeck curves were formed for all samples by 153 
measuring traction from 1-1500 mm/s with a 2 N normal force.  2 N was chosen to provide 154 
contact pressures relevant to oral processing (order of magnitude) found from literature (Hori 155 
et al., 2009)  while maintaining repeatable data as established in previous work by the 156 
authors (Mills et al., 2013). Each sample was measured six times alternating from ascending 157 
and descending speeds to check for hysteresis. Hysteresis can sometimes occur when 158 
samples are physically altered by the shear in the testing process itself, if this is the case 159 
subsequent speed sweeps could drift in value and using an average would not be 160 
appropriate when presenting the final results, this was not evident in the measurements 161 
reported here. Measurements were performed in triplicate and are presented as an average 162 
with error bars of one standard deviation. 163 
2.3 Rheological measurement 164 
Bulk rheology of the products was measured to act as a comparison to the tribology data 165 
obtained. A Bohlin Gemini HR nano rheometer (Malvern, UK) was used; fitted with a 20 mm 166 
4° cone and plate at 20 °C.  Shear rates from 0.01 to 300 s-1 ascending and descending 167 
were applied. Results are presented as an average of three repeats with error bars of one 168 
standard deviation. 169 
2.4 Particle size and shape 170 
A drop of each commercial product was placed onto a microscope slide and a coverslip was 171 
used to prevent dehydration of the sample. A Zeiss Axiosop 2 Plus upright microscope was 172 
used to view each product to directly observe the particle size and shape at x10 173 
magnification. The axiovision programme was used to capture a representative image from 174 
each sample together with a scale bar. The crystals were measured at their widest part in 175 
two perpendicular directions from 3 fields of view where at least 4 crystals were present (a 176 
total of n=12 crystals were included) and the mean diameter reported together with one 177 
standard deviation for each product. Analysis of Variance (ANOVA) tests were performed at 178 
a significance level of 5%. Results were stated to be different when the p value was less 179 
than 0.05. 180 
3 Results and discussion 181 
3.1 Tribology and rheology  182 
The lubricating properties of the medicines were measured to determine if any differences 183 
could be identified for a range of samples. An overall comparison of the five samples is 184 
made as well as two smaller comparisons within the Septrin formulations and the 185 
paracetamol formulations. Figure 1 shows the Stribeck curves collected where the traction 186 
coefficient is plotted as a function of speed for all samples.  Under the conditions studied, 187 
differences in the materials can be observed mainly at low to intermediate speeds. These 188 
differences relate to the lubricating properties and entrainment between the measurement 189 
surfaces of the materials and would highlight differences that could be perceived during 190 
consumption. The oily nature of lactulose as identified in earlier work is evident from the low 191 
traction coefficient values, which demonstrates that this product is likely to coat surfaces 192 
easily.  193 
Gritty or “dry” products are anticipated to show high traction coefficients at low speeds due to 194 
their lack of lubrication and surface coating. Many liquid medicines are suspensions with 195 
particle sizes ranging from 1 to 50 µm (Allen et al., 2005). However, there is currently no 196 
data that correlates grittiness perception in medicines to particle size. This study used 197 
products with particle sizes that are known to be detectable in human panel studies which 198 
also represent typical liquid medicines. The fact that Calpol® does not result in higher friction 199 
values or a gritty mouthfeel despite having particles large enough to be perceived could 200 
suggest that, as suggested by Engelen et al., the particles are not hard enough to affect 201 
perception or that their shape is affecting their perception (Engelen et al., 2005a).  For the 202 
generic paracetamol samples a large difference is identified between the different brands 203 
with the 250 mg/5mL product being more lubricating overall and very similar to the Calpol® 204 
formulation. When compared to viscosity (see Figure 2) at lower shear rates both generic 205 
products behave similarly to each other, with the Calpol® at a reduced viscosity at lower 206 
shear rates, however the 120 mg/5mL product is more shear thinning (i.e. viscosity reduces 207 
with increasing shear rate) which would suggest a reduced ability to support the contacting 208 
surfaces and reduce lubrication for the tribology measurement.  These differences are 209 
expected since the different brands would use different formulations but these changes in 210 
behaviour highlight why two products may have very different feedback on their palatability 211 
despite containing the same quantity of active ingredient. 212 
Both Septrin® formulations show very similar lubrication behaviour and viscosity over the 213 
studied range, which could be expected since they are both from the same manufacturer. 214 
Despite having different concentrations of active ingredient these results suggest that the 215 
excipients likely dominate the material behaviour, so any differences experienced in liking 216 
are expected to be from flavour cues. The approach to maintain this behaviour for both adult 217 
and paediatric formulations may not be the best design approach since differences in 218 
preferences would likely exist at different ages.  219 
These results have demonstrated that tribology can detect differences in oral liquid 220 
medicines which may relate to mouthfeel. There are also further opportunities to use 221 
tribology in a wider range of oral medicines including orally disintegrating tablets, chewable 222 
tablets, oral films and gels. 223 
 224 
  Stribeck curves (coefficient of friction versus speed) of measured samples. Figure 1.225 
Data points are mean values with error bars representing 1 standard deviation 226 
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 228 
 Viscosity measurements of samples over a shear rate range of 0.01 to 1000 Figure 2.229 
s-1. Data points are mean values with error bars representing 1 standard deviation 230 
 231 
3.2 Particle size and shape 232 
Figure 3 shows representative images of each of the products viewed with the microscope. 233 
The mean particle size of the 4 largest particles present in each product was measured 234 
manually via the scale bar from at least 3 representative images. This technique provides a 235 
simple means of measuring the particle size of the largest particles present in each product, 236 
as the larger particles are likely to dominate mouthfeel. 237 
The results in Table 1 compare the mean particle diameter for the largest particles observed 238 
as well as the standard deviation of each. 239 
Table 1. Particle size information of the suspension products tested 240 
Product Mean 
diameter 
(μm) 
Standard 
deviation 
(μm) 
Septrin® Paediatric suspension 40mg/200mg per 5mL (Aspen) 25.28 8.65 
Septrin® adult suspension 80mg/400mg per 5mL (Aspen) 36.90 8.25 
Generic paracetamol sugar free oral suspension 120mg per 5mL 
(Edict) 
50.56 12.41 
Generic paracetamol sugar free oral suspension 250mg per 5mL 
(Pinewood laboratories) 
48.33 19.79 
Calpol® paracetamol sugar free oral suspension 120mg per 5mL 
(McNeil) 
69.72 38.89 
 241 
The particle size varied between products, as did the number of particles present. However, 242 
Calpol® contained particles of the largest dimensions (although not statistically significantly 243 
larger (p>0.05) in this estimated methodology) yet there are no mouthfeel issues associated 244 
with this product. This may also be due to the taste being the most important factor, which 245 
masks potentially problematic mouthfeel. All products had particles greater than 2 µm which 246 
was previously reported as detectable in food by trained adult panels (Engelen et al., 247 
2005a). However, it may be expected that medicines contain particles and grittiness may not 248 
be reported as an issue in such products.  249 
  250 
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 Representative images of the products ((A) = Septrin® Paediatric suspension Figure 3.257 
40mg/200mg per 5mL (Aspen); (B) = Septrin® adult suspension 80mg/400mg per 5mL 258 
(Aspen); (C) = generic paracetamol sugar free oral suspension 120mg per 5mL (Edict); (D) = 259 
generic paracetamol sugar free oral suspension 250mg per 5mL (Pinewood laboratories) 260 
and (E) = Calpol® paracetamol sugar free oral suspension 120mg per 5mL (McNeil)) used to 261 
calculate the diameter of the largest particles present. Scale bar = 50μm.  262 
4 Conclusions 263 
These results highlight the use of tribology as a tool to understand lubrication processes 264 
involving oral liquid medicines and the unique information it can provide. However, like any 265 
physical in vitro technique, it is still difficult to directly relate tribological measurement to 266 
sensory perception and developments therefore additional work is required to better utilise 267 
sensory panel and in vitro data from a range of measurements for future products. The 268 
application of tribology in this context has the potential to add value to the design process by 269 
allowing measurements at a different scale to rheology and more traditional methods. This 270 
could play a crucial role in the rational design of oral liquid medicines with high consumer 271 
acceptability. 272 
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